Personalized Breast Cancer Treatment

141 – 148 of 148

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/V1001122?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
…
12
13
14
15
next »

2007
Mark Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
Gruvberger, Sofia ^LU ; Bendahl, Pär-Ola ^LU ; Saal, Lao H ^LU ; Laakso, Mervi ; Hegardt, Cecilia ^LU ; Edén, Patrik ^LU ; Peterson, Carsten ^LU ; Malmström, Per ^LU ; Isola, Jorma ^LU and Borg, Åke ^LU , et al. (2007) In Clinical Cancer Research 13(7). p.1987-1994
- Contribution to journal › Article
2004
Mark "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers.
Edén, Patrik ^LU ; Ritz, Cecilia ^LU ; Rose, Carsten ^LU ; Fernö, Mårten ^LU and Peterson, Carsten ^LU (2004) In European Journal of Cancer 40(12). p.1837-1841
- Contribution to journal › Article
2001
Mark S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer
Malmström, Per ^LU ; Bendahl, Pär-Ola ^LU ; Boiesen, P ; Brunner, N ; Idvall, Ingrid ^LU and Fernö, Mårten ^LU (2001) In Journal of Clinical Oncology 19(7). p.2010-2019
- Contribution to journal › Article
1999
Mark Estrogen receptor content in adenovirus type 9-induced rat mammary tumors
Ankerst, Jaro ^LU ; Fernö, Mårten ^LU and Jonsson, Nils ^LU (1999) In In Vivo 13(2). p.151-153
- Contribution to journal › Article
1990
Mark Indicators of prognosis in node-negative breast cancer
Sigurdsson, H ; Baldetorp, Bo ^LU ; Borg, Åke ^LU ; Dalberg, M ; Fernö, Mårten ^LU ; Killander, Dick ^LU and Olsson, Håkan ^LU (1990) In New England Journal of Medicine 322(15). p.1045-1053
- Contribution to journal › Article
Mark HER-2/neu amplification predicts poor survival in node-positive breast cancer
Borg, A ^LU ; Tandon, A K ; Sigurdsson, H ; Clark, G M ; Fernö, M ^LU ; Fuqua, S A ; Killander, D ^LU and McGuire, W L (1990) In Cancer Research 50(14). p.7-4332
- Contribution to journal › Article
1989
Mark HER2/neu amplification and comedo type breast carcinoma
Borg, A ^LU ; Linell, F ; Idvall, I ^LU ; Johansson, S ; Sigurdsson, H ; Fernö, M ^LU and Killander, D ^LU (1989) In The Lancet 1(8649). p.9-1268
- Contribution to journal › Letter
1982
Mark Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma
Lindahl, B ^LU ; Alm, P ^LU ; Borg, A ^LU ; Fernö, M ^LU ; Grundsell, H ; Johnsson, J E ; Norgren, A and Trope, Claes (1982) In Anticancer research 2(4). p.7-203
- Contribution to journal › Article

« previous
1
2
…
12
13
14
15
next »